| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $1.72 ▲ +1.15% | Yesterday | $1.69 ▼ -0.48% | Tomorrow's ALX Oncology Holdings Inc. Common Stock (ALXO) setup is anchored to $1.70 and targets $1.72 (+1.15%). The near-term read is upside; watch $1.75 / $1.65 because daily realized volatility is about 5.93%. |
Tomorrow's ALX Oncology Holdings Inc. Common Stock (ALXO) setup is anchored to $1.70 and targets $1.72 (+1.15%). The near-term read is upside; watch $1.75 / $1.65 because daily realized volatility is about 5.93%. | ||||
| Week | $1.76 ▲ +3.58% | Last Week | $1.67 ▼ -1.50% | The 7-day ALX Oncology Holdings Inc. Common Stock model moves from $1.67 to $1.76 (+3.58%). It gives upside momentum context for this stock, so breaks around $1.75 / $1.65 matter more than a single tick. |
The 7-day ALX Oncology Holdings Inc. Common Stock model moves from $1.67 to $1.76 (+3.58%). It gives upside momentum context for this stock, so breaks around $1.75 / $1.65 matter more than a single tick. | ||||
| Month | $1.83 ▲ +7.61% | Last Month | $1.65 ▼ -3.20% | The 1-month ALX Oncology Holdings Inc. Common Stock target is $1.83 (+7.61%), compared with the live reference near $1.70. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month ALX Oncology Holdings Inc. Common Stock target is $1.83 (+7.61%), compared with the live reference near $1.70. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $1.93 ▲ +13.67% | Last Year | $1.60 ▼ -5.74% | The 1-year ALX Oncology Holdings Inc. Common Stock scenario points to $1.93 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year ALX Oncology Holdings Inc. Common Stock scenario points to $1.93 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $2.17 ▲ +27.86% | 5 Years Ago | $1.50 ▼ -11.70% | The 5-year ALX Oncology Holdings Inc. Common Stock view is $2.17 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year ALX Oncology Holdings Inc. Common Stock view is $2.17 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $1.70 | Mid |
| Daily Change | -2.86% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $1.70 | Daily Change | -2.86% |
| Market Cap | $223.73M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.